Abirami Seetharaman

Chennai, TN, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

PELP1 expression is associated with disease progression in inflammation-driven oral cancer.

PELP1 expression is associated with disease progression in inflammation-driven oral cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 25, 2026

PAK1 mediated phosphorylation of ARGLU1 promotes tumorigenic potential of Breast cancer.

PAK1 mediated phosphorylation of ARGLU1 promotes tumorigenic potential of Breast cancer.

Journal: The Journal of biological chemistry
Published: March 04, 2026

Transcriptome Analysis of Human Pancreatic Stellate Cells Co-cultured With PAK1-Modulated Cells Revealed the Role of Cytokine Pathway in Tumor Microenvironment.

Transcriptome Analysis of Human Pancreatic Stellate Cells Co-cultured With PAK1-Modulated Cells Revealed the Role of Cytokine Pathway in Tumor Microenvironment.

Journal: Pancreas
Published: June 28, 2024

Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer.

Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer.

Journal: Molecular cancer therapeutics
Published: May 31, 2024

Elucidating shape-mediated drug carrier mechanics of hematite nanomaterials for breast cancer therapeutics.

Elucidating shape-mediated drug carrier mechanics of hematite nanomaterials for breast cancer therapeutics.

Journal: Journal of materials chemistry. B
Published: March 06, 2024

Doxorubicin loaded thermostable nanoarchaeosomes: a next-generation drug carrier for breast cancer therapeutics.

Doxorubicin loaded thermostable nanoarchaeosomes: a next-generation drug carrier for breast cancer therapeutics.

Journal: Nanoscale advances
Published: November 02, 2023

Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources.

Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources.

Journal: Vaccines
Published: October 27, 2023

Combination of IDO1high and CCL19low expression in the tumor tissue reduces survival in HPV positive cervical cancer.

Combination of IDO1high and CCL19low expression in the tumor tissue reduces survival in HPV positive cervical cancer.

Journal: Journal of reproductive immunology
Published: August 27, 2021

Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate molecule for immunotherapy in cervical cancer.

Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate molecule for immunotherapy in cervical cancer.

Journal: Cancer cell international
Published: November 12, 2020

Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro.

Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro.

Journal: Journal of gynecologic oncology
Published: October 16, 2020

Immunotherapy for cervical cancer: Can it do another lung cancer?

Immunotherapy for cervical cancer: Can it do another lung cancer?

Journal: Current problems in cancer
Published: November 06, 2017
Showing 1-11 of 11

Last Updated: 09/26/2026